These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 4143953

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Biochemical bases of Parkinson disease].
    Colucci d'Amato C, Puccini A, Cristillo A, Vizioli R.
    Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
    [No Abstract] [Full Text] [Related]

  • 3. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Oct; 72(4):595-603. PubMed ID: 4341763
    [No Abstract] [Full Text] [Related]

  • 4. Proceedings: Para-o-methylation of dopamine in human brain.
    Ebinger G, Verheyden R.
    Acta Neurol Belg; 1975 Oct; 75(2):111. PubMed ID: 1155020
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
    Levin SL.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Oct; 72(9):1418-26. PubMed ID: 4349303
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG, Davidson L, Hornykiewicz O.
    J Pharmacol Exp Ther; 1975 Dec; 195(3):453-64. PubMed ID: 489
    [Abstract] [Full Text] [Related]

  • 11. [Neurochemical aspects of parkinsonism. Review of the literature].
    De Mattos JP, Cechela C, Adams JG, De Lima JM.
    Arq Neuropsiquiatr; 1982 Sep; 40(3):289-95. PubMed ID: 6130754
    [Abstract] [Full Text] [Related]

  • 12. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M.
    Sci Basis Med Annu Rev; 1970 Sep; ():276-91. PubMed ID: 4319923
    [No Abstract] [Full Text] [Related]

  • 13. [Disturbances of monoamine metabolism in organic presenile and senile dementia].
    Gottfries CG.
    Lakartidningen; 1974 Mar 27; 71(13):1284-5. PubMed ID: 4823610
    [No Abstract] [Full Text] [Related]

  • 14. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M.
    Psychiatr Neurol Neurochir; 1971 Mar 27; 74(4):331-3. PubMed ID: 5146239
    [No Abstract] [Full Text] [Related]

  • 15. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
    Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F.
    J Neurol Sci; 1973 Dec 27; 20(4):415-55. PubMed ID: 4272516
    [No Abstract] [Full Text] [Related]

  • 16. Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.
    Birkmayer W, Danielczyk W, Neumayer E, Riederer P.
    J Neural Transm; 1974 Dec 27; 35(2):93-116. PubMed ID: 4844103
    [No Abstract] [Full Text] [Related]

  • 17. The metabolism of brain dopamine in human parkinsonism.
    Hornykiewicz O.
    Riv Patol Nerv Ment; 1970 Oct 27; 91(5):281-6. PubMed ID: 5525774
    [No Abstract] [Full Text] [Related]

  • 18. Dopaminergic responses to striatal damage.
    Howells DW, Liberatore GT, Wong JY, Donnan GA.
    J Neurol Sci; 1996 Jul 27; 139(1):125-30. PubMed ID: 8836983
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. L-dopa in Parkinson's syndrome.
    Poskanzer DC.
    N Engl J Med; 1969 Feb 13; 280(7):382-3. PubMed ID: 5764823
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.